News

Check out market updates

Reven tests anti-sepsis drug for treatment of COVID-19

WESTMINSTER — Reven Holdings Inc., a biosciences company developing potential treatments for cancer, viral illnesses and inflammatory disorders, completed this […]
Source: BizWest

Leave a Reply

Your email address will not be published. Required fields are marked *

X